Background
TAVR is becoming a more secure and mature technology. Recently, TAVR has been performed with a "minimalist approach," [4, 5] and the recognition of the TAVR team is gradually weakening. However, under current medical guidelines in China, it is still necessary to prioritize the implementation of a TAVR team for several reasons. First, although TAVR is growing into a safe and standard procedure, it is still a high-risk and complex surgery compared to traditional interventional procedures. Even in the latest clinical trials, the perioperative mortality of TAVR is still 2%-4%, and the incidence of permanent pacemaker implantation, paravalvular leak, and vascular complications is still relatively high. [6, 7] Second, the domestic valve currently listed in China is the first-generation valve, which does not have the function of recycling, relocating, and preventing leakage. There is a high proportion of two-leaf valves and serious calcification in Chinese TAVR patients. [8, 9] Therefore, there is a high risk in performing TAVR in China at present. Third, TAVR is a complex technology, its classical development methods require coordination among multidisciplinary personnel such as cardiology, cardiac surgery, imaging, and anesthesiology. [10] Finally, TAVR has an steep learning curve, [11] and TAVR is more successful when conducting system-based training and team-standardized operations. In order to promote the standardization, safety, and smooth promotion of TAVR in China, it is suggested that the multidisciplinary heart team (MDHT) of TAVR should be established in China to train the team personnel systematically and to promote adherence to the corresponding technical specifications.
Team composition and personnel requirements
Referring to the international guide, [12] it is recommended that the MDHT of TAVR consists of interventional physicians, cardiovascular surgeons (cardiologists), echocardiogram physicians, radiologists, anesthesiologists, nurses, and related professional and technical personnel, and the team must undergo systematic training. TAVR team members are required to include the following: [13] 1. Interventional physicians: The TAVR interventional physicians are the core of the MDHT team. [13] (c) TAVR contraindications. Imaging evaluation is mainly to assess whether the patient's anatomy is suitable for TAVR. It is recommended that the head physician analyze the imaging data of the patient (MSCT) to determine whether the patient is suitable for surgery and to select a valve model 2. Intraoperative: The interventional physician is the main operator of TAVR, and the main points of operation refer to the "Chinese expert consensus on Transcatheter Aortic Valve Replacement" [13] 3. Perioperative management: Patients may be managed by the CCU or other nonsurgeons after surgery, but the interventional physician still needs to play a major role in postoperative management. The relevant doctors should be informed of the surgical situation, complications, and precautions, and relevant treatment strategies should be formulated. Patients should be visited frequently, especially in critical cases. If conditions permit, it is recommended to set up postoperative TAVR ward to manage patients after the surgery 4. Postoperative follow-up: It is recommended that doctors follow up with the patients at 1, 3, 6, and 12 months after the operation, and once a year routinely thereafter. The follow-up contents include the position and function of the prosthetic valve, the heart function, and the complications. The examination items mainly include echocardiography, electrocardiogram (ECG), and other items including brain natriuretic peptide, and blood routine.
Cardiac surgeon
1. Preoperative assessment and screening: Assessment should be made according to the Society of Thoracic Surgeons scoring system, the European System for Cardiac Operative Risk Evaluation score, Weakness Index, the possibility of major organ damage that cannot be improved by surgery, related surgical operation disorders, etc. [2] These factors should be combined with the operation experience of the cardiac center and comprehensively evaluate the surgical risk of patients. When a surgical approach is required, assess the feasibility and safety of the associated approach 2. Intraoperative collaboration and postoperative management: Assist in the treatment of related approaches. For emergent surgical operations, remedial surgery is performed after detailed discussion with the interventional physician.
Radiologists
Imaging evaluation by radiologists is the focus of preoperative assessment and screening of TAVR, of which MSCT is particularly important. 1. MSCT scan technique requires: [14] (i) recommended thickness: ≤1 mm; (ii) ECG gating, taking the end of systolic period (about 40% of the cardiac cycle); (iii) an enhanced computed tomography (CT) scan (injection contrast); (iv) imaging the body from below the neck down to the knee joint, to assess all available peripheral vascular access (femoral artery, subosseous artery, etc.). For patients with aortic stenosis, β-blockers and nitrates should be avoided to prevent hemodynamic complications during examination Aortic root scanning must be done with ECG gating techniques (retrospective or prospective) and a high-pitch scan. The abdominal aorta and iliac femoral artery do not require ECG gating and high-pitch scanning, which can significantly reduce the radiation dose and the dosage of contrast medium 2. MSCT analysis includes: [14] (i) the circumference, area, and diameter of aortic annulus as the main reference for TAVR valve selection; (ii) aortic root anatomy, including coronary artery height, aortic sinus width, ascending aorta width, sinus tube junction, and left ventricular outflow tract; (iii) aortic valve morphology, judged to be two leaf or three lobed, analysis of leaflet thickness, fusion, and calcification (including calcification, distribution, and continuity). The leaflet morphology can also serve as a reference for selection of TAVR valves. (iv) assessment of the vascular approach, including the femoral artery, subclavian artery, carotid artery, ascending aorta, and transapical approach to understand the internal diameter, distortion, and calcification of the approach; (v) coronary artery lesions; (vi) MSCT assists in determining the best angiographic angle of the operation. In addition, intraoperative radiologists should assist in the adjustment of the patient's head for digital subtraction angiography and completing the angiography.
Anesthesiologist
The anesthesiologist is responsible for: 1. Preoperative assessment: The anesthesiologist should check the patient before the operation. By reviewing the patient's medical history, physical examination, laboratory examination, and imaging results, they can comprehensively understand the general situation of the patient, the history of noncardiac disease, and cognitive ability to assess the anesthesia risk. They should ask about medication history and allergy history and make a routine airway assessment. Preoperative medication can help patients to relieve anxiety before induction of anesthesia and also help avoid adverse cardiac events due to tachycardia 2. Intraoperative collaboration: For patients with TAVR, anesthesiologists should open at least one unobstructed venous access (recommended central venous catheter) and monitor invasive blood pressure. The necessary monitoring items during the operation include ECG, finger oxygen saturation, body temperature, end-tidal carbon dioxide partial pressure, central venous pressure, and active clotting time In order to correct any possible arrhythmia, the electrode sheets of external cardioversion should be placed and connected before anesthesia induction. At the beginning of the TAVR operation, general anesthesia (single-lumen endotracheal intubation) is generally recommended. Anesthesia induction should be slow and stable, and the sinus rhythm should be maintained as far as possible during anesthesia management Be careful to maintain adequate preload and avoid using vasodilator drugs to ensure ventricular filling pressure. Norepinephrine or phenylephrine can be used in small doses to maintain systemic resistance, avoid hypotension, and ensure adequate perfusion of the hypertrophic myocardium. To prevent tachycardia, anesthesiologists will also need to avoid severe bradycardia. Possible intravenous anesthetics are etomidate, propofol, ketamine, and opioids such as fentanyl, sufentanil, remifentanil (small dose of intravenous infusion), and possible inhaled anesthetics are sevoflurane, desflurane, muscle relaxants such as rocuronium, and cisatracurium. On the one hand, it is considered that patients with TAVR are generally older. On the other hand, if the tracheal catheter is removed after surgery, benzodiazepines are not recommended. If inhalation anesthetics are selected, attention should be given to controlling the concentration of drug inhalation and avoiding excessive inhibition of myocardium In an experienced TAVR center, the operation can also be performed with a local anesthesia combined with sedation. Local anesthetic sedative prohibition is used in the following situations: severe sleep apnea, predicting poor airway, patients cannot be supine, severe gastroesophageal reflux, mental disorders or communication disorders, or the transesophageal echocardiography must be used during surgery. The sedative drug generally chosen is dexmedetomidine for continuous intravenous infusion. Small doses of opioids can be added to the femoral artery sheath. Before the balloon dilation, propofol is given as needed, with no inhibition of breathing as a criterion. During the operation, the bispectral index can be monitored and maintained at 65-75. The patient's respiratory and circulatory conditions must be closely monitored throughout the procedure and general anesthesia must be prepared as a standby. 
Other personnel
Other personnel include cardiac surgeons who can deal with vascular complications and others such as neurology, respiratory physician, and geriatric staff. These personnel must be fixed, trained to familiarize with, or understand the clinical problems related to TAVR. Although these people are not necessary for a regular TAVR team, they can work together with the TAVR team to deal with related issues when required, such as preoperative assessment and complication handling.
Note: This article is published in the Chinese Journal of interventional cardiology in Chinese simultaneously.
